Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALPIX.PA
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Pixium Vision SA
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 1.16M
- Ent value
- 10.44M
- Price/Sales
- 0.64
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -66.62%
- 1 year return
- -86.61%
- 3 year return
- -83.26%
- 5 year return
- -64.38%
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
ALPIX.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.64 |
| Price to Book | - |
| EV to Sales | 5.80 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 3.08M |
| EPS (TTM) | -9.03 |
| FCF per share (TTM) | -7.11 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.80M |
| Gross profit (TTM) | 996.06K |
| Operating income (TTM) | -19.09M |
| Net income (TTM) | -15.78M |
| EPS (TTM) | -9.03 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 55.37% |
| Operating margin (TTM) | -1061.07% |
| Profit margin (TTM) | -876.99% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.74M |
| Net receivables | 1.11M |
| Total current assets | 5.16M |
| Goodwill | 0.00 |
| Intangible assets | 812.00K |
| Property, plant and equipment | 0.00 |
| Total assets | 6.81M |
| Accounts payable | 1.88M |
| Short/Current long term debt | 8.50M |
| Total current liabilities | 7.00M |
| Total liabilities | 13.02M |
| Shareholder's equity | -6.21M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -12.31M |
| Capital expenditures (TTM) | 105.00K |
| Free cash flow (TTM) | -12.42M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -231.79% |
| Return on Invested Capital | -825.29% |
| Cash Return on Invested Capital | -649.69% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| ALPIX.PA | S&P500 | |
| Current price drop from All-time high | -99.87% | -0.60% |
| Highest price drop | -99.98% | -56.47% |
| Date of highest drop | 20 Dec 2023 | 9 Mar 2009 |
| Avg drop from high | -64.16% | -11.07% |
| Avg time to new high | 415 days | 12 days |
| Max time to new high | 2033 days | 1805 days |
COMPANY DETAILS
Marketcap
1.16M
Marketcap category
Small-cap
Description
Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. It develops PRIMA System, a bionic vision system for patients with vision loss due to retinal degeneration caused by the dry atrophic form of Age-related Macular Degeneration (AMD); and to treat blindness, which replace the normal physiological function of the eye's photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the stimulation to the brain via the intermediary of the optic nerve. The company has collaboration agreements with Stanford University in California, Institute of Ocular Microsurgery in Barcelona, Institut de la Vision in Paris, Moorfields Eye Hospital in London, University Hospital in Bonn, and UPMC in Pittsburgh. Pixium Vision SA was founded in 2011 and is based in Paris, France.
Employees
40
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found